Evidence map›Paper›PMID 41020405›Full record

ReviewAdvanced healthcare materials2026

Microphysiological Systems of Lymphatics and Immune Organs.

Ishita Jain, Ankur Singh, Andrés J García

Abstract readReview
In one paragraph

Review in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ishita JainWoodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Ankur SinghWoodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Andrés J GarcíaWoodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID 0000-0001-6602-2518

Funding

Hydrogel-based Organoids of African-American Lymphomas to Study B Cell Receptor Pathway InhibitorsR01CA266052 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI JEAN L KOFF, Ankur Singh · 2022 to 2026
$2.7M
Hydrogel-based lymphoid tissues for generation of activated human B cells and delivery in vivoR01AI186314 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI Ankur Singh · 2024 to 2026
$2.3M
Hydrogel-Based Aged Immune Organoids to Study Epigenetics and Trajectory of B CellsR01AI181282 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI Ankur Singh · 2024 to 2026
$2.2M
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman LymphomasR01CA238745 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI SINGH, ANKUR · 2020 to 2024
$2.2M
National Institute of Allergy and Infectious Diseases 1R01AI181282-01A1National Institute of Allergy and Infectious Diseases 1R01AI186314-01NCI NIH HHS R01 CA238745NCI NIH HHS R01 CA266052NIAID NIH HHS R01 AI181282NIAID NIH HHS R01 AI186314US National Cancer Institute 5R01CA238745-03
6 · The paper itself

Abstract

Microphysiological systems (MPS) that incorporate engineered blood vasculatures have enabled new opportunities to study human physiology and disease, offering platforms for drug development, tissue modeling, and regenerative medicine. However, most human tissues also contain an equally complex yet underrepresented secondary vascular network, the lymphatic system. Lymphatics play indispensable roles in interstitial fluid drainage, immune cell trafficking, and antigen presentation, and are central to the pathophysiology of diseases such as lymphedema, chronic inflammation, and cancer metastasis. Despite their critical biological functions, lymphatic vessels and associated immune structures, such as lymph nodes, remain absent from current in vitro models. Integrating lymphatics into biomaterials-based MPS is essential for capturing the dynamic interplay between fluid transport, immune surveillance, and tissue homeostasis. This review surveys recent progress in engineering lymphatic microenvironments and immune organoids within biomaterials-based MPS, emphasizing innovative strategies to recreate the biochemical and biophysical complexity of native lymphatic tissues. Advances are highlighted in tunable extracellular matrix platforms, humanized cell sourcing, and precision fabrication techniques, including perfusable, modular, and scalable models. The integration of lymphatic components with multi-organ systems, combined with the application of computational modeling and machine learning, offers unprecedented opportunities to build personalized and physiologically relevant immune models. Incorporating lymphatics into next-generation MPS promises to illuminate fundamental disease mechanisms and accelerate the development of more predictive therapeutic testing platforms with improved clinical translation.

Indexed as

Lymphatic SystemLymphatic VesselsTissue EngineeringAnimalsBiocompatible MaterialsHumansMicrophysiological SystemsBiocompatible Materialshydrogelslymphademalymphaticslymph nodeorgan‐on‐chip

Identifiers

PMID41020405
PMCPMC12927538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.